_id
6915edfabc934aba376b1e5d
Ticker
REVBW
Name
Revelation Biosciences Inc
Exchange
NASDAQ
Address
4660 La Jolla Village Drive, San Diego, CA, United States, 92122
Country
USA
Sector
Industry
Currency
USD
Website
https://www.revbiosciences.com
Description
Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Last Close
0.0125
Volume
73938
Current Price
0.0081
Change
0.0001
Last Updated
2026-01-06T10:10:39.662Z
Image
data:image/webp;base64,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
Ipo Date
2020-11-16T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1943011
Operating Income
-1943011
Interest Expense
-
Pretax Income
-1907176
Net Income
-1907176
Eps
-0.7211223212324268
Dividends Per Share
2769742
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-1900411
Operating Margin
-
Total Other Income Expense Net
35835
Cash
12708489
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
12832423
Property Plant Equipment
23919
Total Assets
12856342
Payables
1034951
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1854507
Equity
11001835
Bs_currency_symbol
USD
Depreciation
6765
Change In Working Capital
306761
Cash From Operations
-1588901
Capital Expenditures
0
Cash From Investing
281967
Cash From Financing
9123519
Net Change In Cash
7534618
Cf_currency_symbol
USD
PE
-
PB
0.0019471603873353852
ROE
-17.335071831199066
ROA
-14.834515136576174
FCF
-1588901
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1943011
Quarters > 0 > income Statement > operating Income
-1943011
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1907176
Quarters > 0 > income Statement > net Income
-1907176
Quarters > 0 > income Statement > eps
-0.7211223212324268
Quarters > 0 > income Statement > dividends Per Share
2769742
Quarters > 0 > income Statement > shares Outstanding
2644733
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1900411
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
35835
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
12708489
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
12832423
Quarters > 0 > balance Sheet > property Plant Equipment
23919
Quarters > 0 > balance Sheet > total Assets
12856342
Quarters > 0 > balance Sheet > payables
1034951
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1854507
Quarters > 0 > balance Sheet > equity
11001835
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1907176
Quarters > 0 > cash Flow > depreciation
6765
Quarters > 0 > cash Flow > change In Working Capital
306761
Quarters > 0 > cash Flow > cash From Operations
-1588901
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
281967
Quarters > 0 > cash Flow > cash From Financing
9123519
Quarters > 0 > cash Flow > net Change In Cash
7534618
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.7211223212324268
Quarters > 0 > ratios > PB
0.0019471603873353852
Quarters > 0 > ratios > ROE
-17.335071831199066
Quarters > 0 > ratios > ROA
-14.834515136576174
Quarters > 0 > ratios > FCF
-1588901
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
7220
Quarters > 1 > income Statement > gross Profit
-7220
Quarters > 1 > income Statement > operating Expenses
2461229
Quarters > 1 > income Statement > operating Income
-2461229
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2444382
Quarters > 1 > income Statement > net Income
-2444382
Quarters > 1 > income Statement > eps
-3.0453137653082836
Quarters > 1 > income Statement > dividends Per Share
3181786
Quarters > 1 > income Statement > shares Outstanding
802670
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2454009
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
16847
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
5173871
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5359920
Quarters > 1 > balance Sheet > property Plant Equipment
35170
Quarters > 1 > balance Sheet > total Assets
5395090
Quarters > 1 > balance Sheet > payables
828894
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1569306
Quarters > 1 > balance Sheet > equity
3825784
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2444382
Quarters > 1 > cash Flow > depreciation
7220
Quarters > 1 > cash Flow > change In Working Capital
517051
Quarters > 1 > cash Flow > cash From Operations
-1919281
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-281967
Quarters > 1 > cash Flow > cash From Financing
3388541
Quarters > 1 > cash Flow > net Change In Cash
1469260
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-3.0453137653082836
Quarters > 1 > ratios > PB
0.001699423438437716
Quarters > 1 > ratios > ROE
-63.892315927924834
Quarters > 1 > ratios > ROA
-45.30752962415826
Quarters > 1 > ratios > FCF
-1919281
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
7221
Quarters > 2 > income Statement > gross Profit
-7221
Quarters > 2 > income Statement > operating Expenses
2094987
Quarters > 2 > income Statement > operating Income
-2094987
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2051085
Quarters > 2 > income Statement > net Income
-2051085
Quarters > 2 > income Statement > eps
-2.11166225511241
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
971313
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2087766
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
43902
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3704611
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3927881
Quarters > 2 > balance Sheet > property Plant Equipment
42390
Quarters > 2 > balance Sheet > total Assets
3970271
Quarters > 2 > balance Sheet > payables
625058
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1089519
Quarters > 2 > balance Sheet > equity
2880752
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2051085
Quarters > 2 > cash Flow > depreciation
7221
Quarters > 2 > cash Flow > change In Working Capital
-979302
Quarters > 2 > cash Flow > cash From Operations
-2794407
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-2794407
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.11166225511241
Quarters > 2 > ratios > PB
0.0027311046907196454
Quarters > 2 > ratios > ROE
-71.1996381500386
Quarters > 2 > ratios > ROA
-51.66108308475669
Quarters > 2 > ratios > FCF
-2794407
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
26964
Quarters > 3 > income Statement > cost Of Revenue
13482
Quarters > 3 > income Statement > gross Profit
13482
Quarters > 3 > income Statement > operating Expenses
1753888
Quarters > 3 > income Statement > operating Income
-1753888
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1725719
Quarters > 3 > income Statement > net Income
-1725719
Quarters > 3 > income Statement > eps
-4.980372520952139
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
346504
Quarters > 3 > income Statement > income Tax Expense
2
Quarters > 3 > income Statement > EBITDA
-1746667
Quarters > 3 > income Statement > operating Margin
-6504.554220442071
Quarters > 3 > income Statement > total Other Income Expense Net
28169
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6499018
Quarters > 3 > balance Sheet > short Term Investments
6492518982
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
6565717
Quarters > 3 > balance Sheet > property Plant Equipment
56332
Quarters > 3 > balance Sheet > total Assets
6622049
Quarters > 3 > balance Sheet > payables
783621
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1913667
Quarters > 3 > balance Sheet > equity
4708382
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1725719
Quarters > 3 > cash Flow > depreciation
7221
Quarters > 3 > cash Flow > change In Working Capital
-2099152
Quarters > 3 > cash Flow > cash From Operations
-3747641
Quarters > 3 > cash Flow > capital Expenditures
17691
Quarters > 3 > cash Flow > cash From Investing
17689
Quarters > 3 > cash Flow > cash From Financing
3687918
Quarters > 3 > cash Flow > net Change In Cash
-42034
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-4.980372520952139
Quarters > 3 > ratios > PB
0.0005961033747898959
Quarters > 3 > ratios > ROE
-36.652060091980644
Quarters > 3 > ratios > ROA
-26.060196775952576
Quarters > 3 > ratios > FCF
-3765332
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-139.64293131582852
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
27923
Annuals > 0 > income Statement > gross Profit
-27923
Annuals > 0 > income Statement > operating Expenses
7975109
Annuals > 0 > income Statement > operating Income
-7975109
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-15038536
Annuals > 0 > income Statement > net Income
-15038536
Annuals > 0 > income Statement > eps
-87.68314384000932
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
171510
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-7947186
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-7063427
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
6499018
Annuals > 0 > balance Sheet > short Term Investments
6492518982
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
6565717
Annuals > 0 > balance Sheet > property Plant Equipment
56332
Annuals > 0 > balance Sheet > total Assets
6622049
Annuals > 0 > balance Sheet > payables
783621
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1913667
Annuals > 0 > balance Sheet > equity
4708382
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-15038536
Annuals > 0 > cash Flow > depreciation
27923
Annuals > 0 > cash Flow > change In Working Capital
-3423072
Annuals > 0 > cash Flow > cash From Operations
-18321276
Annuals > 0 > cash Flow > capital Expenditures
19171
Annuals > 0 > cash Flow > cash From Investing
-19171
Annuals > 0 > cash Flow > cash From Financing
12847764
Annuals > 0 > cash Flow > net Change In Cash
-5492683
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-87.68314384000932
Annuals > 0 > ratios > PB
0.0002950548617338185
Annuals > 0 > ratios > ROE
-319.39923311235157
Annuals > 0 > ratios > ROA
-227.09792694073997
Annuals > 0 > ratios > FCF
-18340447
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
25049
Annuals > 1 > income Statement > gross Profit
-25049
Annuals > 1 > income Statement > operating Expenses
8656664
Annuals > 1 > income Statement > operating Income
-8656664
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-120254
Annuals > 1 > income Statement > net Income
-120254
Annuals > 1 > income Statement > eps
-8.415255423372988
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
14290
Annuals > 1 > income Statement > income Tax Expense
1
Annuals > 1 > income Statement > EBITDA
-8631615
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
8536410
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
11991701
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
12147525
Annuals > 1 > balance Sheet > property Plant Equipment
65084
Annuals > 1 > balance Sheet > total Assets
12212609
Annuals > 1 > balance Sheet > payables
1359898
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5564894
Annuals > 1 > balance Sheet > equity
6647715
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-120254
Annuals > 1 > cash Flow > depreciation
25049
Annuals > 1 > cash Flow > change In Working Capital
982135
Annuals > 1 > cash Flow > cash From Operations
-7286286
Annuals > 1 > cash Flow > capital Expenditures
4
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
14025008
Annuals > 1 > cash Flow > net Change In Cash
6738722
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-8.415255423372988
Annuals > 1 > ratios > PB
0.00001741184752956467
Annuals > 1 > ratios > ROE
-1.8089523994334895
Annuals > 1 > ratios > ROA
-0.9846708430606433
Annuals > 1 > ratios > FCF
-7286290
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
40008
Annuals > 2 > income Statement > gross Profit
-40008
Annuals > 2 > income Statement > operating Expenses
10864511
Annuals > 2 > income Statement > operating Income
-10864511
Annuals > 2 > income Statement > interest Expense
34962
Annuals > 2 > income Statement > pretax Income
-10829549
Annuals > 2 > income Statement > net Income
-10829549
Annuals > 2 > income Statement > eps
-602.7131010685663
Annuals > 2 > income Statement > dividends Per Share
7652325
Annuals > 2 > income Statement > shares Outstanding
17968
Annuals > 2 > income Statement > income Tax Expense
-34962
Annuals > 2 > income Statement > EBITDA
-10839463
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
34962
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5252979
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
5413282
Annuals > 2 > balance Sheet > property Plant Equipment
90133
Annuals > 2 > balance Sheet > total Assets
5503415
Annuals > 2 > balance Sheet > payables
554205
Annuals > 2 > balance Sheet > short Term Debt
2911260
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4450962
Annuals > 2 > balance Sheet > equity
1052453
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-10829549
Annuals > 2 > cash Flow > depreciation
25048
Annuals > 2 > cash Flow > change In Working Capital
-730971
Annuals > 2 > cash Flow > cash From Operations
-11219396
Annuals > 2 > cash Flow > capital Expenditures
4
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
15197646
Annuals > 2 > cash Flow > net Change In Cash
3978250
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-602.7131010685663
Annuals > 2 > ratios > PB
0.00013828722042694543
Annuals > 2 > ratios > ROE
-1028.9817217490947
Annuals > 2 > ratios > ROA
-196.77870921963907
Annuals > 2 > ratios > FCF
-11219400
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
69166
Annuals > 3 > income Statement > gross Profit
-69166
Annuals > 3 > income Statement > operating Expenses
11950485
Annuals > 3 > income Statement > operating Income
-11950485
Annuals > 3 > income Statement > interest Expense
41759
Annuals > 3 > income Statement > pretax Income
-11986837
Annuals > 3 > income Statement > net Income
-11986837
Annuals > 3 > income Statement > eps
-20400.348888661967
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
587.58
Annuals > 3 > income Statement > income Tax Expense
-219776
Annuals > 3 > income Statement > EBITDA
-11933703
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-36352
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1274729
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1912071
Annuals > 3 > balance Sheet > property Plant Equipment
130141
Annuals > 3 > balance Sheet > total Assets
2042212
Annuals > 3 > balance Sheet > payables
596261
Annuals > 3 > balance Sheet > short Term Debt
16752
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2141682
Annuals > 3 > balance Sheet > equity
-99470
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-11986837
Annuals > 3 > cash Flow > depreciation
16782
Annuals > 3 > cash Flow > change In Working Capital
356220
Annuals > 3 > cash Flow > cash From Operations
-11090573
Annuals > 3 > cash Flow > capital Expenditures
131963
Annuals > 3 > cash Flow > cash From Investing
-131963
Annuals > 3 > cash Flow > cash From Financing
8004865
Annuals > 3 > cash Flow > net Change In Cash
-3217671
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-20400.348888661967
Annuals > 3 > ratios > PB
-0.0000478475721323012
Annuals > 3 > ratios > ROE
12050.70574042425
Annuals > 3 > ratios > ROA
-586.9536071671305
Annuals > 3 > ratios > FCF
-11222536
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.7211223212324268
Valuation > metrics > PB
0.0019471603873353852
Valuation > final Score
70
Valuation > verdict
99.8% Undervalued
Profitability > metrics > ROE
-17.335071831199066
Profitability > metrics > ROA
-14.862165937017508
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.16856342601029736
Risk > metrics > Interest Coverage
-287.2152254249815
Risk > final Score
-1089
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.399063337298095
Liquidity > metrics > Quick Ratio
12.399063337298095
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-963
Prev Risks > 1
-168
Prev Risks > 2
-275
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:28:39.382Z
Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Technicals: Can Piedmont Office Realty Trust Inc grow without external funding - July 2025 Snapshot & Free Safe Entry Trade Signal Reports baoquankhu1.vn
Read more →Entry Recap: Is Clean Energy Fuels Corp a stock for growth or value investors - July 2025 Outlook & Fast Gaining Stock Strategy Reports baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Revelation Biosciences Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.